Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
|Videos|January 6, 2017
Using Social Media to Recruit for Cancer Clinical Trials
Author(s)Alicia Staley
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
Advertisement
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
Staley explains that the peer-to-peer network that social media offers would be a great tool to connect patients and researchers across the nation and get more enrollment in clinical trials.
Advertisement
Related to this article
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
Advertisement
Advertisement
Trending on CURE
1
5 Ways to Cope With Scanxiety While Waiting for Cancer Results
2
5 Lung Cancer Survival Numbers Patients Should Know in 2026
3
Living in the After: A Mom's View of Breast Cancer Survivorship
4
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
5